FDA & Prescription Drugs

• Hydroxycut Products Recalled Due To Risk Of Liver Injury

  Chrissie Cole | May 01, 2009 12:11 AM | 0 CommentsCheyenne, WY

  Some Hydroxycut products have been associated with serious liver injuries and as such consumers should immediately stop taking these products. The Food and Drug Administration (FDA) has received...

• AIDS: Still deadly

  Darin Schanker | June 19, 2008 3:41 PM | 1 CommentCheyenne, WY

  Naturally, game 3 of the NBA Finals was a star-studded event. The classic rivalry between the Boston Celtics and the Los Angeles Lakers reigniting after 21 years attracted L.A. celebrities and NBA...

• McKesson Corporation to pay $13.25 Million in Settlements

  Linda Snyder | May 06, 2008 7:51 PM | 0 CommentsCheyenne, WY

  McKesson Corporation has reached an agreement to pay $13.25 million in civil and administrative settlements with the U.S. Drug Enforcement Administration and six U.S. Attorneys for failing to report...

• Vytorin and Zetia Only to be Used as Last Resort

  Linda Snyder | April 03, 2008 1:15 PM | 1 CommentCheyenne, WY

  The American College of Cardiology has recommended that the popular drugs Vytorin and Zetia should only be used after all other cholesterol lowering drugs fail. The panel's spokesman, Harlan...

• Dennis Quaid Sues Baxter for Heparin Overdose

  Linda Snyder | March 18, 2008 3:07 PM | 0 CommentsCheyenne, WY

  Actor Dennis Quaid and his wife Kimberly Buffington filed a lawsuit in December 2007 against Baxter Healthcare Corporation, claiming the drug maker was negligent when packaging different doses of the same drug in similar packaging. Both heparin and the lower dose version, hep-lock are packaged in similar vials with blue backgrounds and very small print on both labels.Quaid's newborn twins, who...

• Some Antidepressant Use May Lead to Bone Loss

  Jenny Albano | July 17, 2007 2:44 PM | 0 CommentsCheyenne, WY

  Selective serotonin reuptake inhibitors (SSRIs), a commonly prescribed class of anitdepressants, have been linked to bone loss in older men and women in three new studies.Researchers studied 2,722 women with an average age of 78, following them for an average of 4.9 years. After adjusting for weight, diet, smoking and other health behaviors, they found that S.S.R.I. users had an average hip bone...

• Anemia Drugs Will Now Carry Warning Label

  Shannon Weidemann | March 29, 2007 2:11 PM | 0 CommentsCheyenne, WY

  Three very popular anemia drugs have had "black box" warning labels added to them by the FDA. Procrit, Epogen, and Aransep are usually given to cancer and kidney patients. Patients that take them have a higher risk of death or life-threatening side effects though.The new boxed warning states that Erythropoiesis-stimulating agents (ESAs) increased the risk of death and serious cardiovascular...

• Adverse effects and deaths reported with Methadone

  Staff Writer | February 05, 2007 9:32 AM | 1 CommentCheyenne, WY

  An article posted on WorstPills.org this month details new FDA warnings to consumers and health care professionals about the adverse effects of pain managing drug methadone. Deaths and life-threatening changes in heart beat and breathing have been reported in association with methadone. The professional product label, also known as a package insert, for methadone carries a black-box warning...

• Fired Johnson & Johnson VP expressed safety concerns

  Staff Writer | December 27, 2006 8:44 AM | 0 CommentsCheyenne, WY

  A former executive for Johnson & Johnson subsidiary Ortho-McNeil has filed a civil lawsuit against his former company for firing him. He alleges that the company unlawfully terminated him in May because of his repeated complaints about the safety of certain drug products, including the Ortho Evra contraceptive patch.An Associated Press article details the suit against J&J:The lawsuit alleges...

• Birth Control Patch Label Warning

  Staff Writer | September 20, 2006 4:00 PM | 0 CommentsCheyenne, WY

  According to the latest news from the FDA, Ortho and FDA notified healthcare professionals and patients aboutchanges to the available prescribing information to inform them of the results of two separate epidemiology studies evaluating the risk of developing a serious blood clot in women using Ortho Evra compared to women using a different oral contraceptive. The first study found that the risk...